lung cancer Archives - Journal for Clinical Studies

Regional News

AstraZeneca and other lung cancer specialists join together to emphasize early screenings

If there is one strong message Camille Hertzka, AstraZeneca vice president and head of oncology, U.S. medical, wants people to take away from lung cancer awareness su...

15 December 2021 Regional News AstraZeneca | Guardant Health

Continue Reading →

Regional News

Novartis looks for silver lining in $2B canakinumab repurposing after 2nd lung cancer failure

Is autoinflammatory disease treatment Ilaris a potential new therapy for non-small cell lung cancer (NSCLC)? After two pivotal trial failures, the answer seems to be ...

26 October 2021 Regional News Ilaris | lung cancer

Continue Reading →

Regional News

Roche ushers early lung cancer into immunotherapy era with Tecentriq FDA approval. Will doctors follow?

Roche’s Tecentriq has ushered in a new era, offering the first immunotherapy option for non-small cell lung cancer (NSCLC) patients right after tumour surgery. But do...

20 October 2021 Regional News immunotherapy | lung cancer

Continue Reading →

news

AZ teams up with G1 on lung cancer combination therapy

AstraZeneca has signed a deal with US group G1 Therapeutics to test the potential of a new combination therapy for lung cancer. The parties have signed a clinical tri...

29 November 2017 news lung cancer | Phase Ib/II study

Continue Reading →

Decentralised Clinical Trials in The EU

RWS – eBook

It’s All About Stem Cells

Covid-19

Current Edition

AstraZeneca and other lung cancer specialists join together to emphasize early screenings

Novartis looks for silver lining in $2B canakinumab repurposing after 2nd lung cancer failure

Roche ushers early lung cancer into immunotherapy era with Tecentriq FDA approval. Will doctors follow?

AZ teams up with G1 on lung cancer combination therapy

Journal for Clinical Studies